Spain

Krka Farmaceutica has been present in Spain since 2011. Marketing started in 2012 with the promotion of three different medicines: Nolpaza (Pantoprazole Krka), Atoris (Atorvastatin Krka) and Clopidogrel Krka. Today we have a 90 INN (international non-proprietary name) portfolio and over 330 SKUs (stock keeping units).

We successfully focus on generic medicines for cardiovascular, gastrointestinal and CNS diseases. In 2019, we launched the first over-the-counter (OTC) medicine Herbion, which paves the way for other OTC products.

Our promotion is split into two business units: a Pharmacy Line with a sales team that covers a large portion of the Spanish pharmacies and a Hospital Line that is focused on visiting specialists such as neurologists, psychiatrists, geriatricians, hematologists and anesthesiologists.

We are most proud of the excellent team we have built – a team of different professionals who make Krka Farmaceutica the company it is today.